Surfactant therapy in neonates | Evidence, Current practice, and complications

The post outlines the Surfactant therapy for neonatal respiratory distress syndrome (RDS) or hyaline membrane disease (HMD). The following topics are covered

  1. Evidence
  2. Importance, 
  3. How it is done - the procedure
  4. Complications of surfactant administration in newborns.



about authors

Ajay Agade | DNB(Pediatrics), FNB(Pediatric Intensive Care), Fellowship in Pediatric pulmonology and LTV

Ajay is a Paediatric Intensivist, currently working in Pediatric Pulmonology & LTV at Great Ormond Street Hospital NHS, London